Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoldPlat Regulatory News (GDP)

Share Price Information for GoldPlat (GDP)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.125 (0.70%)
Bid:
17.50
Ask:
18.50
Spread: 1.00 (5.714%)
Market Cap: £30.74m
GDP Live PriceLast checked at - London Stock Exchange

Intraday GoldPlat Share Chart

Director Appointment

13 Oct 2021 12:18

RNS Number : 9763O
Goldplat plc
13 October 2021
 

13 October 2021

 

Goldplat   plc

( 'Goldplat', the 'Group' or 'the Company')

Director Appointment

 

 

 

Goldplat plc, the AIM quoted gold producer, with international gold recovery operations located in South Africa and Ghana, is pleased to announce the appointment of Mr Martin Ooi to the Board of Goldplat as a Non-Executive Director with immediate effect.

 

A qualified medical doctor, Martin is an experienced entrepreneur and investor. He is the founder and Managing Director of the Serkona Group of private limited companies based in Australia with interests in multiple medical centres, commercial properties, and other unlisted assets. As a director of Goldplat PLC, he intends to focus on capital allocation decisions and helping to maximise the per-share intrinsic value of the company.

 

Werner Klingenberg, CEO of Goldplat commented: "I'm pleased to welcome Martin Ooi to the board who has been a shareholder and a supporter of Goldplat Plc for a long time and looking forward to the value he will add."

Mr Martin See Yeing Ooi, aged 43, holds 48,403,801 Goldplat ordinary shares, representing 28.12% of the issued share capital of the Company. Other than that as set out below, there is no further information to be disclosed under Schedule Two (g) of the AIM Rules.

Martin Ooi is, or has been, a director of the following companies during the previous five years:

Current directorships

Past directorships

Daws Road Medical Pty Ltd

Ooi and Family Custodian Pty Ltd

Ooi and Khoo Family One Pty Ltd

Ooi and Khoo Family Pty Ltd

Ooi Family Investments Pty Ltd

Prema House Medical Centre Management Group Pty Ltd

Prema House Properties Pty Ltd

Serkona Investments One Pty Ltd

Serkona Investments Pty Ltd

Serkona Medical One Pty Ltd

Serkona Medical Pty Ltd

Serkona Properties Pty Ltd

None

 

For further information visit www.goldplat.com, follow on Twitter @GoldPlatPlc or contact:

 

Werner Klingenberg

 

Goldplat plc

(CEO)

 

Tel: +27 (0) 82 051 1071

Colin Aaronson / George Grainger

 

Grant Thornton UK LLP

(Nominated Adviser)

Tel: +44 (0) 20 7383 5100

 

Jessica Cave / Andrew de Andrade

 

WH Ireland Limited

(Broker)

 

Tel: +44 (0) 207 220 1666

 

Tim Thompson / Mark Edwards / Fergus Mellon

Flagstaff Strategic and Investor Communications

Tel: +44 (0) 207 129 1474

goldplat@flagstaffcomms.com

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFMFFDEFSEFS
Date   Source Headline
6th Aug 20212:40 pmRNSExercise of Options and Total Voting Rights
5th Aug 20217:00 amRNSQuarterly Update - Update on 12 months 30 June 21
30th Jul 20217:00 amRNSTotal Voting Rights
23rd Jul 20212:57 pmRNSExercise of Options
20th Jul 20219:38 amRNSReplacement:Update on consideration for Kilimapesa
20th Jul 20217:08 amRNSUpdate on Consideration Receivable for Kilimapesa
20th Jul 20217:00 amRNSCorporate Transactions and Dividend Policy
19th Jul 20217:00 amRNSUpdate on consideration receivable for Kilimapesa
17th May 20217:00 amRNSUpdate on the nine months ended 31 March 2021
26th Apr 20217:00 amRNSCompletion of Sale of Kilimapesa Gold (Pty) Ltd
1st Apr 202110:00 amRNSUpdate on Sale of Kilimapesa
30th Mar 20217:00 amRNSResignation of Director
16th Mar 20211:18 pmRNSReplacement: Interim Results 31 Dec 20
12th Mar 20214:42 pmRNSInterim Results for the six months ended 31 Dec 21
11th Mar 20217:00 amRNSUpdate on sale of Kilimapesa
5th Mar 20217:00 amRNSInterim Results for the six months ended 31 Dec 20
2nd Mar 20217:00 amRNSUpdates on Group Structure and Interim Results
23rd Feb 20217:00 amRNSUpdate on sale of Kilimapesa
19th Feb 20218:24 amRNSUpdate on the Simplifying Group Structure
18th Feb 20217:38 amRNSUpdate on sale of Kilimapesa
15th Feb 20217:00 amRNSSimplifying Group Structure to Reduce Group Costs
8th Feb 20217:00 amRNSUpdate on six months ended 31 December 2020
22nd Jan 20217:00 amRNSLondon South East Investor Webinar
4th Jan 20218:45 amRNSUpdate on Sale of Kilimapesa
31st Dec 20201:23 pmRNSResult of AGM / Directorate Change
30th Dec 20207:15 amRNSNotice of Investor and Analyst Conference Call
9th Dec 20207:00 amRNSNotice of Investor and Analyst Conference Call
7th Dec 202011:46 amRNSPosting of Annual Report and Notice of AGM
30th Nov 20207:00 amRNSPreliminary Unaudited Results for YE 30 Jun 2020
11th Nov 202012:51 pmRNSUpdate on Preliminary Results & Sale of Kilimapesa
26th Oct 20207:17 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSQuarterly Update - Q1 Ended 30 Sept 2020
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:36 pmRNSPrice Monitoring Extension
15th Oct 20207:00 amRNSUpdate on preliminary results & Sale of Kilimapesa
1st Oct 20207:00 amRNSUpdate - Preliminary Results & Sale of Kilimapesa
18th Sep 20207:05 amRNSUpdate on sale of Kilimapesa Pty Limited
3rd Sep 20207:12 amRNSUpdate on the sale of Kilimapesa Pty Limited
26th Aug 20207:32 amRNSHolding(s) in Company
4th Aug 20208:16 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSSigning of term sheet for sale of Kilimapesa Gold
28th Jul 20207:00 amRNSQuarterly Operational Update - Q4 30 June 2020
15th Jul 20204:16 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSExercise of Options
26th Jun 202012:57 pmRNSDirector/PDMR Shareholding
21st May 202010:03 amRNSHolding(s) in Company
14th May 202010:47 amRNSAppointment of Non-executive Director
28th Apr 20208:53 amRNSQuarterly Operational Update - Q3 31 March 2020
17th Apr 202011:49 amRNSHolding(s) in Company
17th Apr 20209:27 amRNSOperational Update in relation to COVID-19

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.